SEC Comment Letter 0000000000-25-000592 to INTENSITY THERAPEUTICS, INC. (INTS)

INTENSITY THERAPEUTICS, INC.
Date: Jan. 21, 2025 · CIK: 0001567264 · Accession: 0000000000-25-000592

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 001-41109

Date

January 21, 2025

Author

Not clearly detected

Form

UPLOAD

Company

INTENSITY THERAPEUTICS, INC.

Letter

January 21, 2025 Lewis H. Bender President & Chief Financial Officer INTENSITY THERAPEUTICS, INC. 1 Enterprise Drive Suite 430 Shelton, CT 06484 Re:INTENSITY THERAPEUTICS, INC. Form 10-K for the year ended December 31, 2023 Filed March 14, 2024 File No. 001-41109 Dear Lewis H. Bender: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

January 21, 2025
Lewis H. Bender
President & Chief Financial Officer
INTENSITY THERAPEUTICS, INC.
1 Enterprise Drive
Suite 430
Shelton, CT 06484
Re:INTENSITY THERAPEUTICS, INC.
Form 10-K for the year ended December 31, 2023
Filed March 14, 2024
File No. 001-41109
Dear Lewis H. Bender:
            We have completed our review of your filing. We remind you that the company and
its management are responsible for the accuracy and adequacy of their disclosures,
notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io